Search

Search Constraints

You searched for: Author/Creator Platten, Michael

Search Results

81. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. Issue 7 (2nd July 2021)

82. Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression. Issue 23 (3rd November 2022)

84. The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas. (1st December 2016)

85. Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101. (January 2023)

86. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial—study protocol. Issue 3 (1st March 2016)

89. Tryptophan‐2, 3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4. Issue 6 (22nd January 2016)

90. Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank. Issue 3 (24th December 2020)